Nonalcoholic Steatosis and Steatohepatitis III. Peroxisomal b-oxidation, PPARa, and steatohepatitis
نویسنده
چکیده
Reddy, Janardan K. Nonalcoholic Steatosis and Steatohepatitis. III. Peroxisomal b-oxidation, PPARa, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 281: G1333–G1339, 2001.—Peroxisomes are involved in the b-oxidation chain shortening of long-chain and very-long-chain fatty acyl-CoAs, long-chain dicarboxylyl-CoAs, the CoA esters of eicosanoids, 2-methyl-branched fatty acyl-CoAs, and the CoA esters of the bile acid intermediates, and in the process, they generate H2O2. There are two complete sets of b-oxidation enzymes present in peroxisomes, with each set consisting of three distinct enzymes. The classic PPARaregulated and inducible set participates in the b-oxidation of straight-chain fatty acids, whereas the second noninducible set acts on branched-chain fatty acids. Long-chain and verylong-chain fatty acids are also metabolized by the cytochrome P-450 CYP4A v-oxidation system to dicarboxylic acids that serve as substrates for peroxisomal b-oxidation. Evidence derived from mouse models of PPARa and peroxisomal b-oxidation deficiency highlights the critical importance of the defects in PPARa-inducible b-oxidation in energy metabolism and in the development of steatohepatitis.
منابع مشابه
Allantoin improves methionine-choline deficient diet-induced nonalcoholic steatohepatitis in mice through involvement in endoplasmic reticulum stress and hepatocytes apoptosis-related genes expressions
Objective(s): Non-alcoholic steatohepatitis (NASH) is defined by steatosis and inflammation in the hepatocytes, which can progress to cirrhosis and possibly hepatocellular carcinoma. However, current treatments are not entirely effective. Allantoin is one of the principal compounds in many plants and an imidazoline I receptor agonist as well. Allantoin has positive eff...
متن کاملبررسی ارتباط سطح سرمی روی با یافتههای پاتولوژی کبد در مبتلایان به کبد چرب غیرالکلی
Background: Nonalcoholic fatty liver disease (NAFLD) includes steatosis, nonalcoholic steatohepatitis, fibrosis and liver cirrhosis. The oxidative stress enzymes are the diagnostic markers to prediction of histologic status of liver in nonalcoholic steatohepatitis disease. The aim of the study was to assessment of relationship between serum Zinc (Zn) levels with pathologic manifestation in pati...
متن کاملPeroxisomal and Mitochondrial Fatty Acid b-Oxidation in Mice Nullizygous for Both Peroxisome Proliferator-activated Receptor a and Peroxisomal Fatty Acyl-CoA Oxidase GENOTYPE CORRELATION WITH FATTY LIVER PHENOTYPE*
Fatty acid b-oxidation occurs in both mitochondria and peroxisomes. Long chain fatty acids are also metabolized by the cytochrome P450 CYP4A v-oxidation enzymes to toxic dicarboxylic acids (DCAs) that serve as substrates for peroxisomal b-oxidation. Synthetic peroxisome proliferators interact with peroxisome proliferator activated receptor a (PPARa) to transcriptionally activate genes that part...
متن کاملPrevention of Nonalcoholic Steatohepatitis in Rats by Two Manganese-Salen Complexes
Background: Nonalcoholic steatohepatitis (NASH), a progressive stage of nonalcoholic fatty liver disease (NAFLD), is characterized by steatosis with inflammation. Investigations have suggested that oxidative stress may play an important role in the progress of NAFLD to NASH. To provide further insights into beneficial effects of antioxidants in NASH prevention, we employed two manganese-supero...
متن کاملLipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
Fatty liver disease (FLD), whether it is alcoholic FLD (AFLD) or nonalcoholic FLD (NAFLD), encompasses a morphological spectrum consisting of hepatic steatosis (fatty liver) and steatohepatitis. FLD has the inherent propensity to progress toward the development of cirrhosis and hepatocellular carcinoma. It is generally difficult to distinguish AFLD from NAFLD on morphological grounds alone desp...
متن کامل